The Asia-Pacific dialysis machines and consumables market is expected to reach USD 4.88 billion by 2031 from USD 3.18 billion in 2023, growing at a CAGR of 5.6% in the forecast period of 2024 to 2031. Market Segmentation Asia-Pacific Dialysis Machines and Consumables Market, By Type (Hemodialysis and Peritoneal), Product Type (Hemodialysis and Peritoneal Dialysis), Disease Type (Chronic and Acute), End Use (Hospitals, Dialysis Centers, Home Care Settings, and Others), Distribution Channel (Direct Tenders, Retail Sales, and Others), Country (China, Japan, India, South Korea, Australia, Singapore, Thailand, Indonesia, Philippines, Malaysia, New Zealand, and Rest of Asia-Pacific) – Industry Trends and Forecast to 2031 Overview of Asia-Pacific Dialysis Machines and Consumables Market Dynamics Driver • Increasing prevalence of kidney diseases Restraint • High cost of treatment in developing countries Opportunity • Government initiatives for various renal-related problems Market Players Some of the major market players operating in the Asia-Pacific dialysis machines and consumables market are: • Fresenius SE & Co. KGaA • Baxter • NIPRO • Evoqua Water Technologies LLC • Medtronic • B. Braun SE • Nikkiso Co., Ltd. • JMS Co. Ltd. • Jafron Biomedical Co., Ltd. • Asahi Kasei Medical Co., Ltd. • Atlantic Biomedical • dialifegroup • Advin Health Care

1 INTRODUCTION 74 1.1 OBJECTIVES OF THE STUDY 74 1.2 MARKET DEFINITION 74 1.3 OVERVIEW OF THE ASIA-PACIFIC DIALYSIS MACHINES AND CONSUMABLES MARKET 74 1.4 CURRENCY AND PRICING 76 1.5 LIMITATIONS 76 1.6 MARKETS COVERED 76 2 MARKET SEGMENTATION 79 2.1 MARKETS COVERED 79 2.2 GEOGRAPHICAL SCOPE 80 2.3 YEARS CONSIDERED FOR THE STUDY 81 2.4 DBMR TRIPOD DATA VALIDATION MODEL 82 2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 85 2.6 MULTIVARIATE MODELLING 86 2.7 MARKET APPLICATION COVERAGE GRID 87 2.8 PRODUCT LIFELINE CURVE 88 2.9 DBMR MARKET POSITION GRID 89 2.10 VENDOR SHARE ANALYSIS 90 2.11 SECONDARY SOURCES 91 2.12 ASSUMPTIONS 91 3 EXECUTIVE SUMMARY 92 4 PREMIUM INSIGHTS 94 4.1 PESTEL ANALYSIS 95 4.2 PORTER’S FIVE FORCES 96 5 MARKET OVERVIEW 97 5.1 DRIVERS 99 5.1.1 INCREASING PREVALENCE OF KIDNEY DISEASES 99 5.1.2 GROWING DEMAND FOR HOME-BASED DIALYSIS TREATMENTS 100 5.1.3 INCREASING AWARENESS ABOUT KIDNEY DISEASES 101 5.1.4 FAVORABLE REIMBURSEMENT POLICIES FOR DIALYSIS TREATMENT IN DEVELOPED COUNTRIES 101 5.2 RESTRAINTS 102 5.2.1 HIGH COST OF TREATMENT IN DEVELOPING COUNTRIES 102 5.2.2 RISK OF BLOODSTREAM INFECTIONS IN PATIENTS UNDERGOING DIALYSIS TREATMENT 103 5.2.3 AVAILABILITY OF KIDNEY TRANSPLANTATION AS AN ALTERNATIVE TREATMENT 104 5.3 OPPORTUNITIES 105 5.3.1 GOVERNMENT INITIATIVES FOR VARIOUS RENAL-RELATED PROBLEMS 105 5.3.2 STRATEGIC PARTNERSHIPS AMONG THE KEY MARKET PLAYERS 105 5.3.3 GROWING ADOPTION OF TECHNOLOGICALLY ADVANCED PRODUCTS 106 5.4 CHALLENGES 107 5.4.1 SHORTAGE OF SKILLED WORKFORCE FOR CONDUCTING THE DIALYSIS PROCEDURE 107 5.4.2 STRICT REGULATIONS IMPOSED BY THE GOVERNMENT AUTHORITIES 108 6 ASIA-PACIFIC DIALYSIS MACHINES AND CONSUMABLES MARKET, BY TYPE 110 6.1 OVERVIEW 111 6.2 HEMODIALYSIS 114 6.2.1 SHORT DAILY HEMODIALYSIS 114 6.2.2 CONVENTIONAL HEMODIALYSIS 114 6.2.3 NOCTURNAL HEMODIALYSIS 114 6.3 PERITONEAL 115 6.3.1 AUTOMATED PERITONEAL DIALYSIS 115 6.3.2 CONTINUOUS AMBULATORY PERITONEAL DIALYSIS 115 7 ASIA-PACIFIC DIALYSIS MACHINES AND CONSUMABLES MARKET, BY PRODUCT TYPE 116 7.1 OVERVIEW 117 7.2 HEMODIALYSIS 120 7.2.1 CONSUMABLES 121 7.2.2 MACHINE 122 7.3 PERITONEAL DIALYSIS 123 8 ASIA-PACIFIC DIALYSIS MACHINES AND CONSUMABLES MARKET, BY DISEASE TYPE 125 8.1 OVERVIEW 126 8.2 CHRONIC 129 8.2.1 HEMODIALYSIS 129 8.2.1.1 SHORT DAILY HEMODIALYSIS 130 8.2.1.2 CONVENTIONAL HEMODIALYSIS 130 8.2.1.3 NOCTURNAL HEMODIALYSIS 130 8.2.2 PERITONEAL 130 8.2.2.1 AUTOMATED PERITONEAL DIALYSIS 130 8.2.2.2 CONTINUOUS AMBULATORY PERITONEAL DIALYSIS 130 8.3 ACUTE 131 8.3.1 HEMODIALYSIS 131 8.3.1.1 SHORT DAILY HEMODIALYSIS 132 8.3.1.2 CONVENTIONAL HEMODIALYSIS 132 8.3.1.3 NOCTURNAL HEMODIALYSIS 132 8.3.2 PERITONEAL 132 8.3.2.1 AUTOMATED PERITONEAL DIALYSIS 132 8.3.2.2 CONTINUOUS AMBULATORY PERITONEAL DIALYSIS 132 9 ASIA-PACIFIC DIALYSIS MACHINES AND CONSUMABLES MARKET, BY END USE 133 9.1 OVERVIEW 134 9.2 HOSPITALS 137 9.2.1 CHRONIC 137 9.2.2 ACUTE 137 9.3 DIALYSIS CENTERS 138 9.3.1 CHRONIC 138 9.3.2 ACUTE 138 9.4 HOME CARE SETTINGS 139 9.4.1 CHRONIC 139 9.4.2 ACUTE 139 9.5 OTHERS 140 10 ASIA-PACIFIC DIALYSIS MACHINES AND CONSUMABLES MARKET, BY DISTRIBUTION CHANNEL 141 10.1 OVERVIEW 142 10.2 DIRECT TENDERS 145 10.3 RETAIL SALES 145 10.4 OTHERS 146 11 ASIA-PACIFIC DIALYSIS MACHINES AND CONSUMABLES MARKET, BY REGION 147 11.4 ASIA-PACIFIC 309 11.4.1 JAPAN 320 11.4.2 SOUTH KOREA 330 11.4.3 CHINA 341 11.4.4 INDIA 352 11.4.5 MALAYSIA 362 11.4.6 THAILAND 373 11.4.7 AUSTRALIA 384 11.4.8 SINGAPORE 395 11.4.9 INDONESIA 405 11.4.10 PHILIPPINES 415 11.4.11 REST OF ASIA-PACIFIC 426 12 ASIA-PACIFIC DIALYSIS MACHINES AND CONSUMABLES MARKET: COMPANY LANDSCAPE 527 12.1 COMPANY SHARE ANALYSIS: ASIA-PACIFIC 527 13 SWOT ANALYSIS 531 14 COMPANY PROFILE 532 14.1 FRESENIUS SE & CO. KGAA 532 14.1.1 COMPANY SNAPSHOT 532 14.1.2 REVENUE ANALYSIS 532 14.1.3 COMPANY SHARE ANALYSIS 533 14.1.4 PRODUCT PORTFOLIO 533 14.1.5 RECENT DEVELOPMENT 534 14.2 BAXTER 535 14.2.1 COMPANY SNAPSHOT 535 14.2.2 REVENUE ANALYSIS 535 14.2.3 COMPANY SHARE ANALYSIS 536 14.2.4 PRODUCT PORTFOLIO 536 14.2.5 RECENT DEVELOPMENT 536 14.3 NIPRO 537 14.3.1 COMPANY SNAPSHOT 537 14.3.2 REVENUE ANALYSIS 537 14.3.3 COMPANY SHARE ANALYSIS 538 14.3.4 PRODUCT PORTFOLIO 538 14.3.5 RECENT DEVELOPMENT 538 14.4 EVOQUA WATER TECHNOLOGIES LLC 539 14.4.1 COMPANY SNAPSHOT 539 14.4.2 REVENUE ANALYSIS 539 14.4.3 COMPANY SHARE ANALYSIS 540 14.4.4 PRODUCT PORTFOLIO 540 14.4.5 RECENT DEVELOPMENT 541 14.5 MEDTRONIC 542 14.5.1 COMPANY SNAPSHOT 542 14.5.2 REVENUE ANALYSIS 542 14.5.3 COMPANY SHARE ANALYSIS 543 14.5.4 PRODUCT PORTFOLIO 543 14.5.5 RECENT DEVELOPMENT 544 14.6 ADVIN HEALTH CARE 545 14.6.1 COMPANY SNAPSHOT 545 14.6.2 PRODUCT PORTFOLIO 545 14.6.3 RECENT DEVELOPMENT 545 14.7 ASAHI KASEI MEDICAL CO., LTD 546 14.7.1 COMPANY SNAPSHOT 546 14.7.2 REVENUE ANALYSIS 546 14.7.3 PRODUCT PORTFOLIO 547 14.7.4 RECENT DEVELOPMENT 548 14.8 ATLANTIC BIOMEDICAL 549 14.8.1 COMPANY SNAPSHOT 549 14.8.2 PRODUCT PORTFOLIO 549 14.8.3 RECENT DEVELOPMENT 550 14.9 B. BRAUN SE 551 14.9.1 COMPANY SNAPSHOT 551 14.9.2 PRODUCT PORTFOLIO 551 14.9.3 RECENT DEVELOPMENT 551 14.10 DIALIFEGROUP 552 14.10.1 COMPANY SNAPSHOT 552 14.10.2 PRODUCT PORTFOLIO 552 14.10.3 RECENT DEVELOPMENT 553 14.11 JAFRON BIOMEDICAL CO., LTD 554 14.11.1 COMPANY SNAPSHOT 554 14.11.2 PRODUCT PORTFOLIO 554 14.11.3 RECENT DEVELOPMENT 554 14.12 JMS CO. LTD 555 14.12.1 COMPANY SNAPSHOT 555 14.12.2 REVENUE ANALYSIS 555 14.12.3 PRODUCT PORTFOLIO 556 14.12.4 RECENT DEVELOPMENT 556 14.13 NIKKISO CO., LTD 557 14.13.1 COMPANY SNAPSHOT 557 14.13.2 REVENUE ANALYSIS 557 14.13.3 PRODUCT PORTFOLIO 558 14.13.4 RECENT DEVELOPMENT 559 15 QUESTIONNAIRE 560 16 RELATED REPORTS 563